Department of Biochemistry and Molecular Medicine, CIIViM, School of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo León, Mexico.
IBMMTG, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Jalisco, Mexico.
Ann Hepatol. 2024 Sep-Oct;29(5):101517. doi: 10.1016/j.aohep.2024.101517. Epub 2024 Jun 7.
Liver fibrosis remains a complication derived from a chronic Hepatitis C Virus (HCV) infection even when it is resolved, and no liver antifibrotic drug has been approved. Molecular mechanisms on hepatocytes and activation of hepatic stellate cells (HSCs) play a central role in liver fibrogenesis. To elucidate molecular mechanisms, it is important to analyze pathway regulation during HSC activation and HCV infection.
We evaluate the fibrosis-associated molecular mechanisms during a co-culture of human HSCs (LX2), with human hepatocytes (Huh7) that express HCV NS5A or Core protein. We evaluated LX2 activation induced by HCV NS5A or Core expression in Huh7 cells during co-culture. We determined a fibrosis-associated gene expression profile in Huh7 that expresses NS5A or Core proteins during the co-culture with LX2.
We observed that NS5A induced 8.3-, 6.7- and 4-fold changes and that Core induced 6.5-, 1.8-, and 6.2-fold changes in the collagen1, TGFβ1, and timp1 gene expression, respectively, in LX2 co-cultured with transfected Huh7. In addition, NS5A induced the expression of 30 genes while Core induced 41 genes and reduced the expression of 30 genes related to fibrosis in Huh7 cells during the co-culture with LX2, compared to control. The molecular pathways enriched from the gene expression profile were involved in TGFB signaling and the organization of extracellular matrix.
We demonstrated that HCV NS5A and Core protein expression regulate LX2 activation. NS5A and Core-induced LX2 activation, in turn, regulates diverse fibrosis-related gene expression at different levels in Huh7, which can be further analyzed as potential antifibrotic targets during HCV infection.
即使慢性丙型肝炎病毒 (HCV) 感染得到解决,肝脏纤维化仍然是一种并发症,而且尚无肝脏抗纤维化药物获得批准。肝细胞和肝星状细胞 (HSCs) 的激活的分子机制在肝纤维化发生中起核心作用。为了阐明分子机制,分析 HSCs 激活和 HCV 感染期间的途径调节非常重要。
我们评估了在人 HSCs (LX2) 与人肝细胞 (Huh7) 的共培养中,HCV NS5A 或核心蛋白表达期间与纤维化相关的分子机制。我们评估了共培养中 Huh7 细胞中 HCV NS5A 或核心表达诱导的 LX2 激活。我们确定了在 Huh7 中表达 NS5A 或核心蛋白的与纤维化相关的基因表达谱,同时与 LX2 共培养。
我们观察到 NS5A 诱导了 8.3 倍、6.7 倍和 4 倍的变化,而 Core 诱导了 LX2 共培养的 Huh7 中胶原 1、TGFβ1 和 timp1 基因表达分别增加了 6.5 倍、1.8 倍和 6.2 倍。此外,与对照相比,NS5A 诱导了 30 个基因的表达,而 Core 诱导了 41 个基因的表达,并降低了共培养中 Huh7 细胞中 30 个与纤维化相关的基因的表达。从基因表达谱中富集的分子途径涉及 TGFB 信号转导和细胞外基质的组织。
我们证明了 HCV NS5A 和核心蛋白表达调节 LX2 的激活。NS5A 和 Core 诱导的 LX2 激活,反过来,又在不同水平调节 Huh7 中不同的纤维化相关基因表达,这可以进一步分析为 HCV 感染期间的潜在抗纤维化靶点。